Press Releases
These are news releases that are related to our Investor efforts. Releases are listed in chronological order and are archived by year. Sign-up to receive news as it is released using the email and RSS tools below.
Aug 20, 2018Therapix Biosciences Ltd. (Nasdaq: TRPX) a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments, issued today its financial summary - second...
- Jul 17, 2018
Therapix Biosciences Ltd. (NASDAQ: TRPX), a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments, announced today positive results in its...
- Jul 12, 2018
Therapix Biosciences Ltd. (Nasdaq: TRPX) ("Therapix") a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments, announced that today that it...
- Jun 27, 2018
Therapix Biosciences Ltd. (Nasdaq: TRPX) a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments, provides updates and dates in connection...
- Jun 11, 2018Dr. Bloch, M.D of Yale University and member of Therapix's SAB committee, to present Therapix' s Phase IIa study results in Tourette Syndrome
Therapix Biosciences Ltd. (Nasdaq: TRPX) ("Therapix" or the "Company"), a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments, announces...